Tyra biosciences to participate in upcoming investor conferences

Carlsbad, calif. , may 25, 2023 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that management will participate in the following investor conferences: td cowen's 4th annual oncology innovation summit: todd harris, ceo of tyra, will participate in a virtual fireside chat on tuesday, may 30th, 11:00 am – 11:25 am et.
TYRA Ratings Summary
TYRA Quant Ranking